Ángel Balmaseda

Datos Biográficos

ID7010801
NOMBREÁngel Balmaseda
NOMBRESÁngel
APELLIDOBalmaseda
FIRMABALMASEDA Á
AFILIACIONESMinisterio de Salud
ORCID0000-0003-1174-4235
VERIFICADOSí
TOTAL DE OBRAS6
TOTAL DE CITAS0
TOTAL COMO AUTOR6
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2017
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0

  • Evaluación de la incidencia de la enfermedad del virus respiratorio sincitial en un estudio de Cohorte de Nacimiento Prospectivo en Managua, Nicaragua

    Open AccessJohn Kubale, Guillermina Kuan et al.ARTICLETranslating the Americas2025

    This text is a Spanish translation of the following article: "Assessing the Incidence of Symptomatic Respiratory Syncytial Virus Illness Within a Prospective Birth Cohort in Managua, Nicaragua." It was published by Oxford University Press for the Infectious Diseases Society of America on July 29, 2019: https://doi.org/10.1093/cid/ciz585 Encontramos una carga sustancial de VSR en niños nicaragüenses menores de 2 años. Alrededor de 1/3 de las muert…

  • Enhancing capacities in genomic surveillance capabilities for Sars-CoV-2 and dengue virus

    Open AccessSully Márquez, Gerald Vasquez-Aleman et al.ARTICLEPLOS Global Public Health2025

    Latin American countries have faced limited access to new scientific technologies for many years due to restricted budgets for research programs, which has hindered local scientific development. These research disparities became especially evident during the COVID-19 pandemic, as lower-middle-income countries (LMICs) like Ecuador and Nicaragua had restricted access to genomic surveillance protocols, sequencing technologies, and adequate infrastru…

  • Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019

    Open AccessYou Li, Xin Wang et al.ARTICLEThe Lancet2022

    BACKGROUND: Respiratory syncytial virus (RSV) is the most common cause of acute lower respiratory infection in young children. We previously estimated that in 2015, 33·1 million episodes of RSV-associated acute lower respiratory infection occurred in children aged 0-60 months, resulting in a total of 118 200 deaths worldwide. Since then, several community surveillance studies have been done to obtain a more precise estimation of RSV associated co…

  • Sars-CoV-2 and endemic coronaviruses

    Open AccessAaron M Frutos, John Kubale et al.ARTICLEPLOS Global Public Health2022

    It has been proposed that as SARS-CoV-2 transitions to endemicity, children will represent the greatest proportion of SARS-Co-V-2 infections as they currently do with endemic coronavirus infections. While SARS-CoV-2 infection severity is low for children, it is unclear if SARS-CoV-2 infections are distinct in symptom presentation, duration, and severity from endemic coronavirus infections in children. We compared symptom risk and duration of ende…

  • Beyond efficacy in water containers

    Open AccessJorge Arosteguí, Josefina Coloma et al.ARTICLEBMC Public Health2017

    ISRCTN 27581154

  • Development of in-house serological methods for diagnosis and surveillance of chikungunya

    Open AccessÁngel Balmaseda, Saira Saborío Galo et al.ARTICLERevista Panamericana de Salud…2017

    Objective. To develop and evaluate serological methods for chikungunya diagnosis and research in Nicaragua. Methods. Two IgM ELISA capture systems (MAC-ELISA) for diagnosis of acute chikungunya virus (CHIKV) infections, and two Inhibition ELISA Methods (IEM) to measure total antibodies against CHIKV were developed using monoclonal antibodies (mAbs) and hyperimmune serum at the National Virology Laboratory of Nicaragua in 2014–2015. The sensitivit…